Key result
The binding site of PAb 402 on SV40 large T-antigen is blocked by mRNP interaction, whereas the N-terminal (PAb 416) and C-terminal (PAb 423) binding sites remain accessible.
The study maps the binding sites of specific monoclonal antibodies on SV40 large T-antigen and demonstrates that the PAb 402 binding site is blocked by interaction with mRNPs.
Preclinical SV40 findings warrant caution before any clinical translation; extends epitope mapping but leaves open in vivo relevance.
Immune complexes of simian virus 40 large T-antigen with monoclonal papovavirus protein antibodies PAb 416, PAb 402, or PAb 423 were bound to protein-A-Sepharose and then cleaved into discrete fragments by limited tryptic proteolysis. PAb 402 protected a specific cleavage site, located approximately within amino acid residues 450-500, from tryptic proteolysis; PAb 423 protected another site within residues 675-699. As shown by immunoblotting, 125I-labeled PAb 416 was bound to a 17-kDa N-terminal fragment of large T-antigen (amino acid residues 1-130), and PAb 423 was bound to several overlapping fragments derived from the C terminus of large T-antigen. These monoclonal antibodies were then used as accessibility probes to study the interaction of mRNPs with cytoplasmic large T-antigen. Whereas small T-antigen and nuclear large T-antigen were fully immunoreactive, cytoplasmic large T-antigen reacted poorly with PAb 402 or polyclonal antibodies unless the mRNP moiety was removed by treatment with EDTA/RNase A. In contrast, mRNP/T-antigen complexes were fully immunoreactive with PAb 416 or PAb 423 and did not require treatment with EDTA/RNase A. The results suggest that the binding site of PAb 402 is blocked due to the interaction with mRNPs whereas the N-terminal binding site of PAb 416 and the C-terminal binding site of PAb 423 remain accessible to antibodies.
No takes yet. Share an insight, caveat, or question.
Schwyzer et al. (1983) studied this question. Monoclonal antibodies (PAb 416, PAb 402, PAb 423) was evaluated on Binding sites on SV40 large T-antigen. The binding site of PAb 402 on SV40 large T-antigen is blocked by mRNP interaction, whereas the N-terminal (PAb 416) and C-terminal (PAb 423) binding sites remain accessible.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: